Jane J. Zara

Array ( [id] => 7289186 [patent_doc_number] => 20040110156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of NRF expression' [patent_app_type] => new [patent_app_number] => 10/317271 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20167 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110156.pdf [firstpage_image] =>[orig_patent_app_number] => 10317271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730722 [patent_doc_number] => 20030186912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides' [patent_app_type] => new [patent_app_number] => 10/314647 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9461 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186912.pdf [firstpage_image] =>[orig_patent_app_number] => 10314647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276312 [patent_doc_number] => 20040235763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Treatment of HSV-related pathologies using ssDNA' [patent_app_type] => new [patent_app_number] => 10/313828 [patent_app_country] => US [patent_app_date] => 2002-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13616 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235763.pdf [firstpage_image] =>[orig_patent_app_number] => 10313828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726810 [patent_doc_number] => 20060057570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Antisense modulation of hematopoietic cell protein tyrosine kinase expression' [patent_app_type] => utility [patent_app_number] => 10/497299 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25667 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057570.pdf [firstpage_image] =>[orig_patent_app_number] => 10497299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469052 [patent_doc_number] => 20040102394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of huntingtin interacting protein 2 expression' [patent_app_type] => new [patent_app_number] => 10/303292 [patent_app_country] => US [patent_app_date] => 2002-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19796 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102394.pdf [firstpage_image] =>[orig_patent_app_number] => 10303292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 616587 [patent_doc_number] => 07144999 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'Modulation of hypoxia-inducible factor 1 alpha expression' [patent_app_type] => utility [patent_app_number] => 10/304126 [patent_app_country] => US [patent_app_date] => 2002-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21807 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/144/07144999.pdf [firstpage_image] =>[orig_patent_app_number] => 10304126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469132 [patent_doc_number] => 20040102405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of squalene synthase expression' [patent_app_type] => new [patent_app_number] => 10/304125 [patent_app_country] => US [patent_app_date] => 2002-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20348 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102405.pdf [firstpage_image] =>[orig_patent_app_number] => 10304125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469126 [patent_doc_number] => 20040102404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of KU86 expression' [patent_app_type] => new [patent_app_number] => 10/304124 [patent_app_country] => US [patent_app_date] => 2002-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19971 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102404.pdf [firstpage_image] =>[orig_patent_app_number] => 10304124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465683 [patent_doc_number] => 20040101856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of MAD2-like 1 expression' [patent_app_type] => new [patent_app_number] => 10/304109 [patent_app_country] => US [patent_app_date] => 2002-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23097 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101856.pdf [firstpage_image] =>[orig_patent_app_number] => 10304109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469066 [patent_doc_number] => 20040102396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of BCL2-associated athanogene 5 expression' [patent_app_type] => new [patent_app_number] => 10/303327 [patent_app_country] => US [patent_app_date] => 2002-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19517 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102396.pdf [firstpage_image] =>[orig_patent_app_number] => 10303327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465675 [patent_doc_number] => 20040101854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of BCL2-associated athanogene expression' [patent_app_type] => new [patent_app_number] => 10/304105 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19365 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101854.pdf [firstpage_image] =>[orig_patent_app_number] => 10304105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 23315 [patent_doc_number] => 07794967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Method and kit for detection of novel pathogen inhibitors' [patent_app_type] => utility [patent_app_number] => 10/495617 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6753 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794967.pdf [firstpage_image] =>[orig_patent_app_number] => 10495617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874428 [patent_doc_number] => 20030194725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Methods for identifying and validating potential drug targets' [patent_app_type] => new [patent_app_number] => 10/299991 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23074 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20030194725.pdf [firstpage_image] =>[orig_patent_app_number] => 10299991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474199 [patent_doc_number] => 20040097451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of nidogen expression' [patent_app_type] => new [patent_app_number] => 10/300611 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19977 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097451.pdf [firstpage_image] =>[orig_patent_app_number] => 10300611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766131 [patent_doc_number] => 20030100531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Antisense inhibition of Interleukin-15 expression' [patent_app_type] => new [patent_app_number] => 10/299881 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22527 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100531.pdf [firstpage_image] =>[orig_patent_app_number] => 10299881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470541 [patent_doc_number] => 20040096835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of TNFSF14 expression' [patent_app_type] => new [patent_app_number] => 10/300424 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19850 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096835.pdf [firstpage_image] =>[orig_patent_app_number] => 10300424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847434 [patent_doc_number] => 20030166601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Novel colloid synthetic vectors for gene therapy' [patent_app_type] => new [patent_app_number] => 10/290406 [patent_app_country] => US [patent_app_date] => 2002-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 45451 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166601.pdf [firstpage_image] =>[orig_patent_app_number] => 10290406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668793 [patent_doc_number] => 20030113777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222' [patent_app_type] => new [patent_app_number] => 10/284059 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33023 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113777.pdf [firstpage_image] =>[orig_patent_app_number] => 10284059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860564 [patent_doc_number] => 20030091572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Methods and compositions for the treatment and diagnosis of pain disorders using 2047' [patent_app_type] => new [patent_app_number] => 10/282907 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23743 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20030091572.pdf [firstpage_image] =>[orig_patent_app_number] => 10282907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683172 [patent_doc_number] => 20030119036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Methods of using 48149, a human aminopeptidase family member' [patent_app_type] => new [patent_app_number] => 10/281904 [patent_app_country] => US [patent_app_date] => 2002-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 50870 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119036.pdf [firstpage_image] =>[orig_patent_app_number] => 10281904 [rel_patent_id] =>[rel_patent_doc_number] =>)